WallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Stock

Overview
ForecastEarningsDividendOwnership
$62.61+0.70 (1.13%)
Updated Apr 9, 2021
BMY Price
$62.61
Fair Value Price
N/A
Market Cap
$141.48B
52 Week Low
$54.07
52 Week High
$67.16
P/E
-15.69x
P/B
3.74x
P/S
3.3x
PEG
N/A
Dividend Yield
3.66%
Revenue
$42.52B
Earnings
-$9.02B
Gross Margin
72.3%
Operating Margin
-16.21%
Profit Margin
-21.2%
Debt to Equity
2.13
Operating Cash Flow
$14B
Beta
0.66
Next Earnings
May 5, 2021
Ex-Dividend
Mar 31, 2021
Next Dividend
May 3, 2021

Zen Score

Expand Score
High
Medium
Low
31
Industry average

Reasons for this score

BMY is good value based on its book value relative to its share price (3.74x), compared to the US market average (-0.01x)
Valuation
BMY is good value based on its book value relative to its share price (3.74x), compared to the US Drug Manufacturers - General industry average (5.16x)
Valuation
BMY's Earnings (EBIT) of -$6.89B are insufficient to safely cover interest payments on company debt ($50.68B)
Financials

1 of 9

BMY News

Valuation

BMY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-15.69x
Industry
8.49x
Market
18.56x

BMY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.74x
Industry
5.16x
Market
-0.01x
BMY is good value based on its book value relative to its share price (3.74x), compared to the US market average (-0.01x)
Valuation
BMY is good value based on its book value relative to its share price (3.74x), compared to the US Drug Manufacturers - General industry average (5.16x)
Valuation

BMY's financial health

Profit margin

Revenue
$11.1B
Net Income
-$10.0B
Profit Margin
-90.6%
BMY's Earnings (EBIT) of -$6.89B are insufficient to safely cover interest payments on company debt ($50.68B)
Financials
BMY's profit margin has decreased (-34.4%) in the last year from (13.2%) to (-21.2%)
Financials

Assets to liabilities

Assets
$118.5B
Liabilities
$80.6B
Debt to equity
1.34
BMY's short-term assets ($30.19B) exceed its short-term liabilities ($19.08B)
Financials
BMY's long-term liabilities ($61.52B) exceed its short-term assets ($30.19B)
Financials
BMY's debt has increased relative to shareholder equity (2.13), over the past 5 years ago (1.21)
Financials
BMY's debt to equity ratio (2.13) is considered high
Financials

Cash flow

Operating
$3.7B
Investing
-$12.1B
Financing
$3.5B
BMY's operating cash flow ($14.05B) is sufficient to service the company's debt ($50.68B)
Financials

Bristol Myers Squibb Stock FAQ

What is Bristol Myers Squibb's quote symbol?

(NYSE: BMY) Bristol Myers Squibb trades on the NYSE under the ticker symbol BMY. Bristol Myers Squibb stock quotes can also be displayed as NYSE: BMY.

What is the 52 week high and low for Bristol Myers Squibb (NYSE: BMY)?

(NYSE: BMY) Bristol Myers Squibb's 52-week high was $67.16, and its 52-week low was $54.07. It is currently -6.77% from its 52-week high and 15.79% from its 52-week low.

How much is Bristol Myers Squibb stock worth today?

(NYSE: BMY) Bristol Myers Squibb currently has 2,259,751,518 outstanding shares. With Bristol Myers Squibb stock trading at $62.61 per share, the total value of Bristol Myers Squibb stock (market capitalization) is $141.48B.

Bristol Myers Squibb stock was originally listed at a price of $47.32 in Dec 31, 1997. If you had invested in Bristol Myers Squibb stock at $47.32, your return over the last 23 years would have been 32.33%, for an annualized return of 1.23%.

How much is Bristol Myers Squibb's stock price per share?

(NYSE: BMY) Bristol Myers Squibb stock price per share is $62.61 today (as of Apr 9, 2021).

What is Bristol Myers Squibb's Market Cap?

(NYSE: BMY) Bristol Myers Squibb's market cap is $141.48B, as of Apr 11, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bristol Myers Squibb's market cap is calculated by multiplying BMY's current stock price of $62.61 by BMY's total outstanding shares of 2,259,751,518.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.